NovaBridge Biosciences (NBP) Capital Expenditures (2019 - 2024)
NovaBridge Biosciences (NBP) posted quarterly Capital Expenditures of -$38000.0 for Q4 2024, down 3700.0% on a QoQ basis from -$1000.0 in Q3 2024.
NovaBridge Biosciences (NBP) Capital Expenditures (2019 - 2024) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Capital Expenditures for 3 consecutive years, with -$38000.0 the latest figure, recorded in Q4 2024.
- Quarterly Capital Expenditures changed N/A year-over-year to -$38000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2025 was -$39000.0 (down 103.2% YoY) and the FY2025 annual result came in at -$7000.0, up 85.42% from the prior year.
- Capital Expenditures slipped to -$38000.0 in Q4 2024 per NBP's latest filing, from -$1000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for NBP reached as high as $1.9 million in Q4 2020 and fell as low as -$668360.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Dec 31, 2020 | 1.93 Mn |
| Dec 31, 2020 | 1.93 Mn |
| Sep 30, 2020 | -668,359.95 |
| Sep 30, 2020 | -668,359.95 |
| Dec 31, 2019 | 2.39 Mn |
| Dec 31, 2019 | 2.39 Mn |